STUDY OF CARDIOMYOPATHY IN DIABETES MELLITUS ON 2nd STAGE

Article Sidebar

PDF (Русский)
Issue: Vol. 5 No. 3 : Eurasian Journal of Medical and Natural Sciences
Section: Articles
Published:
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Main Article Content

Младших научный сотрудник, Институт биофизики и биохимии при Национальном университете Узбекистана.
nad1ra.idrsv@icloud.com
Магистрант, Национальный университет Узбекистана.
nad1ra.idrsv@icloud.com
Доцент кафедры физиологии человека животных, Национальный университет Узбекистана.
nad1ra.idrsv@icloud.com

Abstract:

Cardiomyopathy in diabetes mellitus (DM) is a complex disease characterized by structural and functional changes in the heart muscle. At the second stage of the disease, progressive changes are observed, including myocardial hypertrophy, fibrosis and energy metabolism disorders. This article discusses the mechanisms of cardiomyopathy development in DM stage 2, the effect of hyperglycemia, oxidative stress and inflammatory processes on the myocardium, as well as modern methods of diagnosis and treatment, including drug and non-drug approaches.

Keywords:

Article Details

How to Cite:

Ходжиев , С. ., Идриисова , Н. ., & Кахоров , Б. . (2025). STUDY OF CARDIOMYOPATHY IN DIABETES MELLITUS ON 2nd STAGE. Eurasian Journal of Medical and Natural Sciences, 5(3), 27–32. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/46726

References:

Kannel, W. B., & McGee, D. L. (1979). Diabetes and cardiovascular disease: The Framingham study. JAMA, 241(19), 2035–2038. https://doi.org/10.1001/jama.1979.03300430035028

Fisman, E. Z., & Tenenbaum, A. (2009). The impact of diabetes on cardiovascular disease. Diabetes Care, 32(Suppl 2), S360–S367. https://doi.org/10.2337/dc09-S360

Kannel, W. B., & Vasan, R. S. (2009). Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Archives of Internal Medicine, 169(8), 755–760. https://doi.org/10.1001/archinternmed.2009.72

Boudina, S., & Abel, E. D. (2007). Diabetic cardiomyopathy, causes and effects. Reviews in Endocrine & Metabolic Disorders, 8(1), 31-39. https://doi.org/10.1007/s11154-007-9040-5

American Diabetes Association. (2020). 11. Cardiovascular disease and risk management: Standards of medical care in diabetes—2020. Diabetes Care, 43(Supplement 1), S111–S134. https://doi.org/10.2337/dc20-S011

Aguero, J., & Tarazón, E. (2013). Cardiac involvement in diabetes: Clinical implications of the diabetic cardiomyopathy. Endocrine Research, 38(4), 155-169. https://doi.org/10.3109/07435800.2013.773435

Manczak, M., & Muntner, P. (2018). Diabetes and heart failure: A review. American Journal of Cardiovascular Disease, 8(3), 67-76.

Packer, M., & Myerson, M. (2014). Diabetic cardiomyopathy: Pathophysiology and clinical implications. Heart Failure Clinics, 10(4), 477-485. https://doi.org/10.1016/j.hfc.2014.07.005.

Yarkinboeva, M. R., & Kahorov, B. A. (2024). SPECIFIC CHARACTERISTICS OF THE DETERMINATION OF BIOLOGICAL TRACES OF CRIME. Spectrum Journal of Innovation, Reforms and Development, 28, 32-33.

Kakhorov, B. A., Rasulova, S. L., Zhumakulova, G. S., & Shavkatova, H. R. (2024). COMPLEX EVALUATION OF BIOSTIMULANTS FOR PREVENTION OF IMMUNE SYSTEM DISORDERS AND HIGHLY PRODUCTIVE COWS AND IMPROVEMENT OF MILK QUALITY. American Journal Of Biomedical Science & Pharmaceutical Innovation, 4(01), 39-45.

Kahorov, B. A., & Rasulova, S. L. (2023). INFLUENCE OF MODIFIED PEPTIDES FROM THE FETAL THYMUS ON THE ACTIVITY OF T-LYMPHOCYTES AND NATURAL KILLERS IN EXPERIMENTAL VIRAL HEPATITIS. American Journal Of Biomedical Science & Pharmaceutical Innovation, 3(12), 48-55.

GARIB, F. Y., KAKHOROV, B. A., KHUZHAMKULOVA, M. Z., & KUCHBOEV, A. E. (2021). Effect of modified peptides from fetal thymus on the activity of T-lymphocytes and natural killers and interferonindual activity of sanogen and betaleukin. International Journal of Pharmaceutical Research (09752366), 13(3).

Kayumov, K., Kuchkarova, L., & Kakhorov, B. (2021). Etiology of Pancreatitis and Rutin Treatment of the Disease. Annals of the Romanian Society for Cell Biology, 585-589.

Adilbekov, T. T., & Kakharov, B. A. (2021). PHARMACOLOGY SUPPLY OF THE PROCESS OF PHYSICAL PREPARATION OF ATHLETES. Academic research in educational sciences, 2(2), 1128-1133.

ZAYNITDINOVA, D., & KHYZHAMKULOVA, M. Bolta KAKHOROV. MUTATIONAL VARIABILITY OF BARLEY IN DIFFERENT ALTITUDE ZONES. (in Russian)

Kakhorov, B. A., Rasulova, S. L., Khaitova, F. B., Tukhtaeva, E. I., & Kataeva, Yu. A. (2023). Effect of peptide biostimulants on the immune system in experimental hepatitis. (in Russian)

KAKHOROV, B. (2024). EFFECT OF MODIFIED PEPTIDES FROM FETAL THYMUS ON THE ACTIVITY OF T-LYMPHOCYTES AND NATURAL KILLERS.World of Scientific news in Science, 2(6), 382-397. (in Russian)